FDA Clearance Tracker · P170027-S012
TherOx® DownStream® Cartridge (DSC-2)
Last checked: Nov 20, 2026Latest source record: Jun 6, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 6, 2024
Approved
Time to decision
216 days
Received Nov 3, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170027-S012
- Device name
- TherOx® DownStream® Cartridge (DSC-2)
- Applicant
- Zoll Circulation, Inc.
- Applicant location
- San Jose, CA
- Received
- Nov 3, 2023
- Decided
- Jun 6, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P170027
Device type
- Device type
- System, oxygen, aqueous (MWG)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at ZOLL Circulation Facility (ERN/FEI: 301061700, 2000 Ringwood Ave, San Jose, CA, 95131) for the manufacturing of the TherOx DownStream® Cartridge
Source documents
Other decisions for Zoll Circulation, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250979 · Decided Oct 15, 2025 · 198 days after receipt
Device type: Hyperthermia Monitor (NZE) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.